Clinical usefulness of the branched DNA assay version 2 in predicting the efficacy of interferon treatment in a group of chronic HCV patients based on serotype

Hepatology Research

Volumn 20, Issue 1, 2001, Pages 9-17

  Mahmood, Sabina ^a   Nakata, Kenichi ^a   Sho, Miho ^a   Kimura, Tomomi ^a   Manabe, Yuko ^a   Kinoyama, Shingo ^a   Ito, Toshio ^a   Yamada, Gotaro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

bDNA assay; Complete response; Interferon; Serotype; Viral load

Indexed keywords

DNA; INTERFERON; VIRUS RNA;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SEROTYPE; STATISTICAL ANALYSIS; VIRUS LOAD;

EID: 0035067919     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(00)00118-2     Document Type: Article

References (19)

1. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis
2. Chronic hepatitis C: The viral load per liver cell before treatment as a new marker to predict long-term response to interferon-alpha therapy
3. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis infection
4. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection
5. Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon
6. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection
7. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotypes of hepatitis C virus
8. Efficacy of interferon alpha therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level
9. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C
10. Disappearance of serum hepatitis C virus RNA within two days after one dose interferon administration is predictive for response to high-dose interferon-alpha-2b treatment for chronic hepatitis
11. Pathophisiology and treatment of hepatitis C
12. Accurate quantification of hepatitis C virus (HCV) RNA from HCV genotypes by using branched-DNA technology
13. Comparison of the enzyme-linked immunosorbant assay III, and polymerase chain reaction method in the detection of hepatitis C virus infection in haemodialysis patients
14. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor Assay, and an in-house limiting dilution method
15. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia
16. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays
17. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA
18. Fundamental and clinical evaluation of HCV RNA by branched DNA probe-II assay
19. Changes of HCV-RNA level for one year or longer in patients with chronic hepatitis C, genotype 1b